We collected information about Logicbio Therapeutics Inc Hours for you. Follow the liks to find out everything about Logicbio Therapeutics Inc Hours.
https://www.logicbio.com/
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare diseases. Learn More
https://www.nasdaq.com/market-activity/stocks/logc/after-hours
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
https://mayfieldrecorder.com/2021/12/02/marshall-wace-llp-invests-180000-in-logicbio-therapeutics-inc-nasdaqlogc.html
Marshall Wace LLP acquired a new position in shares of LogicBio Therapeutics, Inc. (NASDAQ:LOGC) in the 2nd quarter, Holdings Channel reports. The fund acquired 40,568 shares of the company’s stock, valued at approximately $180,000. Several other large investors also recently bought and sold shares of the company. Morgan Stanley lifted its stake in shares …
https://www.barrons.com/market-data/stocks/logc
Complete LogicBio Therapeutics Inc. stock information by Barron's. View real-time LOGC stock price and news, along with industry-best analysis. ... After Hours Vol. 351. Price at close $3.1400. 0 ...
https://www.logicbio.com/contact
Offices LogicBio Therapeutics 65 Hayden Ave. Lexington, MA 02421 617-245-0399. Social media. Follow us on Twitter and LinkedIn. Media inquiries. Jenna Urban Berry & Company Public Relations [email protected]. 212-253-8881. Adam Daley Berry & Company Public Relations [email protected] 212-253-8881
https://www.logicbio.com/about-us
At LogicBio, we are committed to delivering genetic medicine to pediatric patients with rare diseases. We are initially targeting rare liver disorders where it is critically important to treat patients early in life, before irreversible damage occurs. We believe our foundational platform technology, GeneRide, is well-suited to this goal because ...
https://investor.logicbio.com/news-releases/news-release-details/logicbio-therapeutics-announces-early-clinical-trial-results
LEXINGTON, Mass., Oct. 18, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company, today announced clinical trial results demonstrating the first-ever in vivo genome editing in children. Early data from the company's Phase 1/2 SUNRISE clinical trial showed measurable levels of albumin-2A, a technology-related …
https://markets.businessinsider.com/news/stocks/logicbio-therapeutics-to-participate-in-upcoming-investor-conferences-1030966782
LogicBio Therapeutics to Participate in Upcoming Investor Conferences. LEXINGTON, Mass., Nov. 11, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine ...
https://rocketreach.co/logicbio-therapeutics-inc-email-format_b4440290faaaecec
LogicBio Therapeutics , Inc. uses 3 email formats. The most common LogicBio Therapeutics , Inc. email format is first '.' last (ex. [email protected]) being used 40.0% of the time. Other common formats are first_initial last (ex. [email protected]) and first (ex. [email protected]) .
https://www.logicbio.com/pipeline
LogicBio Publications. Lisowski L et al. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature. 2014 Feb 20;506(7488):382-6. Epub 2013 Dec 25. Barzel A, et al. Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nature. 2015 Jan 15;517(7534):360-4. Epub 2014 Oct 29. Nygaard ...
Searching for Logicbio Therapeutics Inc Hours?
You can just click the links above. The info is collected for you.
